Nicotine pouches are small, white packets that deliver nicotine through the lining of your mouth without containing any tobacco leaf. You place one between your upper lip and gum, leave it there for 20 to 40 minutes, and the nicotine absorbs through your oral tissue into your bloodstream. They’ve become one of the fastest-growing nicotine products on the market, sold in a range of strengths from 3 mg to 15 mg per pouch and in flavors like mint, citrus, cinnamon, and coffee.
What’s Inside a Nicotine Pouch
The pouch itself is a small, permeable sachet about the size of a piece of chewing gum. Inside, you’ll find nicotine (either extracted from tobacco plants or chemically synthesized), a plant-based filler called microcrystalline cellulose (essentially refined wood pulp), sweeteners like xylitol or maltitol, flavorings, and preservatives. The key distinction from older oral nicotine products is that there is no actual tobacco in the pouch: no cut leaf, no ground tobacco, no powder from the plant itself. The nicotine is isolated and added as a standalone ingredient.
This matters because it sets nicotine pouches apart from traditional smokeless tobacco like snus or dip, which contain processed tobacco leaf. Swedish snus and nicotine pouches look nearly identical and are used the same way, tucked under the lip. But because pouches skip the tobacco leaf entirely, they contain lower levels of toxic compounds than snus. That tobacco-free composition is also the reason they’re legally sold in countries where smokeless tobacco is banned.
How Nicotine Gets Into Your System
When you place a pouch against your gum, moisture from your saliva dissolves the nicotine and it passes through the thin tissue lining your mouth (called the buccal mucosa) into nearby blood vessels. This is a slower delivery route than smoking. With a cigarette, nicotine reaches peak blood concentration in about 5 to 8 minutes. With a pouch, that peak takes anywhere from 20 to 65 minutes.
The total amount of nicotine your body absorbs depends heavily on the strength of the pouch. A 4 mg pouch, the most commonly used strength, delivers roughly 92% of the total nicotine exposure you’d get from a cigarette, but at a lower peak concentration and spread over a longer window. Lower-strength pouches (1.5 to 2 mg) deliver significantly less nicotine than a cigarette. Higher-strength pouches (8 mg and above) actually deliver more total nicotine than smoking.
Flavor also plays a role. Flavored pouches produce significantly higher nicotine exposure and peak concentration than unflavored versions of the same strength, likely because the flavoring agents affect how readily nicotine crosses the oral tissue.
Available Strengths and How to Use Them
Most brands sell pouches across a range of strengths:
- 3 mg: Designed for new users or occasional use
- 6 mg: A step up for people switching from lighter nicotine habits
- 9 mg: A mid-range option for regular users
- 12 mg: For experienced users with higher tolerance
- 15 mg: The strongest widely available option
To use one, you tuck a pouch between your upper lip and gum, typically off to one side near the front teeth or premolars. Most people keep it in place for about 30 minutes. You don’t need to chew it or spit. Some tingling or a slight burning sensation is normal at first, especially with higher strengths. When you’re done, you remove and discard the pouch.
Side Effects on Your Mouth and Body
The most consistently reported side effects are local, meaning they show up right where you place the pouch. A systematic review of the clinical evidence found that oral mucosal changes at the placement site are common. These range from slight wrinkling of the tissue to white, leathery-looking lesions, and they tend to worsen with the number of pouches used per day and how long someone has been using them. In one study, 9 out of 12 regular users had visible white lesions on the gum tissue near their upper front teeth and premolars.
Other reported side effects include dry mouth, gum soreness, gum blisters, a strange jaw sensation, sore throat, nausea, upset stomach, and dizziness. One study found gum recession in 54 to 57% of users, though researchers noted this rate didn’t change significantly over the study period. Most of these effects are more common at higher nicotine strengths and with heavier daily use.
Addiction Potential
Nicotine pouches deliver nicotine, and nicotine is addictive regardless of its source. The slower absorption compared to cigarettes means the initial “hit” is less intense, which in theory gives pouches a somewhat lower abuse potential per use. A 4 mg pouch produces a peak nicotine concentration that’s about 69% of what a cigarette delivers. But total exposure over the life of a single pouch is nearly equivalent to a cigarette, which means the brain still gets a substantial dose of nicotine, just on a more gradual curve.
That slower delivery doesn’t eliminate dependence risk. Researchers have raised specific concerns about flavored pouches, which boost both total nicotine exposure and peak concentration above what unflavored products deliver. Combined with wide availability, discreet use (no smoke, no vapor, no spitting), and aggressive marketing, the worry is that pouches can establish nicotine dependence in people who wouldn’t have started with cigarettes, particularly younger users.
Regulatory Status in the U.S.
The FDA regulates nicotine pouches as tobacco products, even though they contain no tobacco leaf, because the nicotine is derived from or related to the tobacco plant. Manufacturers must submit premarket tobacco product applications (PMTAs) to legally sell their products. In January 2025, the FDA authorized 20 ZYN nicotine pouch products (10 flavors, each in 3 mg and 6 mg strengths) for sale following what the agency described as an extensive scientific review.
The manufacturer of ZYN has also submitted modified risk tobacco product (MRTP) applications, which would allow the company to market these pouches as carrying lower risk than cigarettes. As of mid-2025, those applications are under substantive scientific review, and a scientific advisory committee has held meetings to evaluate the evidence. No modified risk authorization has been granted yet.
Synthetic nicotine briefly created a regulatory loophole, since products using lab-made nicotine rather than tobacco-extracted nicotine weren’t clearly under FDA jurisdiction. Congress closed that gap, and the FDA now regulates synthetic nicotine products under the same framework as tobacco-derived ones.